Exploring barriers to optimal anticoagulation for atrial fibrillation: interviews with clinicians

BACKGROUND: Warfarin, the most commonly used antithrombotic agent for stroke prophylaxis in atrial fibrillation (AF), requires regular monitoring, frequent dosage adjustments, and dietary restrictions. Clinicians’ perceptions of barriers to optimal AF management are an important factor in treatment....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Decker, Carole, Garavalia, Linda, Garavalia, Brian, Simon, Teresa, Loeb, Matthew, Spertus, John A, Daniel, William C
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2012
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3426274/
https://ncbi.nlm.nih.gov/pubmed/22936848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JMDH.S33045
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak